Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer

Clinical trial NCT05733351 · TERMINATED

Trial details

NCT number: NCT05733351
Sponsor: Emory University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Castration-Sensitive Prostate Carcinoma Metastatic Prostate Adenocarcinoma Stage IVB Prostate Cancer AJCC v8

Start date: 2023-08-03
Primary completion: 2025-06-12
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.